![](/img/cover-not-exists.png)
ESTIMATING THE COST TO SOCIETY FOR EXENATIDE QW AND INSULIN GLARGINE IN THE UNITED STATES FOR THE TREATMENT OF TYPE 2 DIABETES
Wang, B.C., Nguyen, H., Furnback, W., Guzauskas, G.F., Hurd, J., Garrison, L.P.Volume:
19
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.03.1288
Date:
May, 2016
File:
PDF, 60 KB
english, 2016